Journals / Turkish Journal of Urology / 2017 / Cilt: 43 - Sayı: 4

Effect of sildenafil citrate in testosterone induced benign prostate hyperplasia rat model

Benign prostat hiperplazisi oluşturulan ratlarda sildenafil sitratın etkinliği

Pages
434–438
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The body weights were measured and theprostates were removed.Results: The mean weights of rats were 288±31.93, 345±23.23 and 294±32.86 g in Groups 1, 2 and 3, respectively.The mean prostate weights of rats were 0.74±0.18, 1.3±0.13 and 0.72±0.24 g in Groups 1, 2, and 3, respectively.Group 2 had statistically significantly higher prostate weights than the other groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Efficacy of treatments for benign prostate hyperplasia (BPH) is limited because the disease hascomplex etiopathogenesis.
📊
Key Findings & Data:Recent studies have demonstrated the presence of phosphodiesterase-5 (PDE-5)receptors in prostate tissue.
💡
Conclusion & Impact:The body weights were measured and theprostates were removed.Results: The mean weights of rats were 288±31.93, 345±23.23 and 294±32.86 g in Groups 1, 2 and 3, respectively.The mean prostate weights of rats were 0.74±0.18, 1.3±0.13 and 0.72±0.24 g in Groups 1, 2, and 3, respectively.Group 2 had statistically significantly higher prostate weights than the other groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Efficacy of treatments for benign prostate hyperplasia (BPH) is limited because the disease hascomplex etiopathogenesis. Recent studies have demonstrated the presence of phosphodiesterase-5 (PDE-5)receptors in prostate tissue. We investigated efficacy of sildenafil citrate in testosteron - induced BPH in rats.Material and methods: The rats were divided into three groups. Each groups had 7 rats. Group 1 was controlgroup. Testosteron propionate 3 mg/kg/day was injected subcutaneously for two weeks in Group 2. The sameprocedure was done for Group 3 and sildenafil citrate was added to water at daily doses of 2 mg/kg for twoweeks. The rats were euthanized with intraperitoneal pentobarbital. The body weights were measured and theprostates were removed.Results: The mean weights of rats were 288±31.93, 345±23.23 and 294±32.86 g in Groups 1, 2 and 3, respectively.The mean prostate weights of rats were 0.74±0.18, 1.3±0.13 and 0.72±0.24 g in Groups 1, 2, and 3, respectively.Group 2 had statistically significantly higher prostate weights than the other groups (p

Özet

Amaç: Benign prostat hiperplazisi (BPH) etyopatogenezinin kompleks olması nedeniyle tedavilerdeki etkinlik sınırlı olmaktadır. Son yıllarda çalışmalarda prostat dokusunda fosfodiesteraz tip 5 (PDE-5) reseptörleri gösterilmiştir. Çalışmamızda testosteron ile indüklenen BPH oluşturulmuş ratlarda sildenafil sitratın etkinliğini araştırdık. Gereç ve yöntemler: Yirmi bir adet rat 3 gruba ayrıldı. Birinci grup kontrol grubuydu. , İkinci grup 2 hafta boyunca testosteron verilerek deneysel BPH oluşturulan gruptu. Üçüncü gruba ise ikinci grup gibi BPH oluşturuldu ve beslenme sıvılarına sildenafil sitrat eklendi.Ratlara intraperitoneal 100 mg/kg pentbarbital ile ötenazi uygulandı. Vücüt ağırlıları ölçüldü ve prostat dokusu çıkartıldı. Bulgular: Ratların ağrıklıkları gruplara göre sırasıyla 288±31,93, 345±23,23 ve 294±32,86 gr idi. Prostat ağırlıkları sırasıyla 0,74±0,18, 1,3±0,13 ve 0,72±0,24 gr olarak bulundu. Grup 2 ile diğerleri arasında istatistiksel anlamlı fark bulundu (p

🔖

Cite This Article

ERCAN, F., KARAMAN, M. İ., ÇALIŞKAN, S., KELEŞ, M. O., KUTLUHAN, M. A., TOK, O. E., ÖZTÜRK, M. İ. (2022). Effect of sildenafil citrate in testosterone induced benign prostate hyperplasia rat model. Turkish Journal of Urology, Cilt: 43 - Sayı: 4, 434–438. https://ajindex.com/articles/614432

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ploumidou K, Kyroudi-Voulgari A, Perea D, Anastasiou I, Mitropoulos D. Effect of a Hypercholesterolemic Diet on Serum Lipid Profile, Plasma Sex Steroid Levels, and Prostate Structure in Rats. Urology 2010
  2. [CrossRef] Riberio DL, Pinto ME, Maeda SY, Taboga SR, Goes RM. High fat induced obesity associated with insulin resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate. Cell Tissue Res 2012
  3. [CrossRef] Saha I,Chatterjee A, Mondal A, Maiti BRM, Chatterji U. Arecoline augments cellular proliferation in the prostate gland of male Wistar rats. Toxicol Appl Pharmacol 2011
  4. [CrossRef] Gonzales C,Revilla JL, Rubio J, Gasco M, Gonzales GF. Effect of red maca(Lepidium meyenii) on prostate zinc levels in rats with testosterone induced prostatic hyperplasia. Andrologia 2012
  5. [CrossRef] Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, et al. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 2007
  6. [CrossRef] Bittencourt JA, Tano T, Gajar SA, Resende AC, de Lemos Neto M, Damião R, et al. Relaxant effects of sildenafil on the human isolated bladder neck. Urology 2009
  7. [CrossRef] Werkstrom V, Hedlund P, Lee T, Andersson KE. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder. BJU Int 2009
  8. [CrossRef] Truss MC, Stief CG, Uckert S, Becker AJ, Wefer J, Schultheiss D, et al. Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside. World J Urol 2001
  9. [CrossRef] Truss MC, Stief CG, Uckert S, Becker AJ, Schultheiss D, Machtens S, et al. Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder. World J Urol 2000
  10. [CrossRef] Andersson KE, Garcia Pascual A, Persson K, Forman A, Tøttrup A. Electrically-induced, nerve mediated relaxation of rabbit urethra involves nitric oxide. J Urol 1992
  11. [CrossRef] Werkstrom V, Svensson A, Andersson KE, Hedlund P. Phosphodiesterase 5 in the female pig and human urethra: Morphological and functional aspects. BJU Int 2006
  12. [CrossRef] Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, et al. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med